Brain Imaging, Cognitive Evaluation Link TOMM40 Alterations to Alzheimer's Risk in Healthy Patients
July 14, 2010
Brain Imaging, Cognitive Evaluation Link TOMM40 Alterations to Alzheimer's Risk in Healthy Patients
Studies presented at an international conference this week suggest that TOMM40 genotyping could be a useful diagnostic strategy for predicting which healthy people with a family history of Alzheimer's will develop the disease early.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Researchers Publish Data on Gene Variant Associated with Late-Onset Alzheimer's Disease
January 6, 2010 / Pharmacogenomics Reporter - Takeda to Use Zinfandel's TOMM40 Test in Alzheimer's Development Program for Actos
January 12, 2011 / Pharmacogenomics Reporter - Rodent Study Suggests Low-Dose Pioglitazone May Improve Cognitive Function in Alzheimer's Patients
July 25, 2012 / Pharmacogenomics Reporter - Adding Alzheimer's Risk Option, 23andMe Revives Questions on Utility of DTC Genomics
April 20, 2011 / Pharmacogenomics Reporter - Quest Study Finds Sanger-based BRAF Mutation Test More Sensitive than Roche's Cobas Test
June 13, 2012 / Pharmacogenomics Reporter